Pentobarbital augments pulmonary vasoconstrictor response to cyclooxygenase inhibition

D. P. Nyhan, B. B. Chen, David Fehr, H. M. Goll, P. A. Murray

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We utilized multipoint pulmonary vascular pressure-flow (P/Q̇) plots to investigate the effects of pentobarbital sodium anesthesia on regulation of the pulmonary circulation by endogenous metabolites of the cyclooxygenase pathway. Our specific objective was to characterize the effects of two chemically dissimilar inhibitors of the cyclooxygenase pathway, indomethacin and sodium meclofenamate, on the pulmonary vascular P/Q̇ relationship measured in conscious and pentobarbital-anesthetized dogs. P/Q̇ plots were generated by graded constriction of the thoracic inferior vena cava, which produced stepwise decreases in Q̇. Controlled ventilation during pentobarbital anesthesia (30 mg/kg iv) allowed the matching of systemic arterial and mixed venous blood gases to conscious values. Pentobarbital had no net effect on the base-line P/Q̇ relationship compared with that measured in conscious dogs. Cyclooxygenase pathway inhibition with either indomethacin (5 mg/kg iv) or meclofenamate (2.5 mg/kg iv) resulted in active, flow-independent pulmonary vasoconstriction (P < 0.01) in both conscious and pentobarbital-anesthetized dogs. However, the magnitude of the pulmonary vasoconstrictor response to indomethacin was increased (P < 0.05) over a broad range of Q̇, and the pulmonary vasoconstrictor response to meclofenamate was increased (P < 0.05) over the entire range of Q̇ in pentobarbital-anesthetized compared with conscious dogs. Thus regulation of the base-line pulmonary vascular P/Q̇ relationship by endogenous metabolites of the cyclooxygenase pathway in conscious dogs is altered during pentobarbital anesthesia.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume257
Issue number4
StatePublished - 1989

Fingerprint

Vasoconstrictor Agents
Pentobarbital
Prostaglandin-Endoperoxide Synthases
Lung
Meclofenamic Acid
Dogs
Indomethacin
Blood Vessels
Anesthesia
Pulmonary Circulation
Cyclooxygenase Inhibitors
Inferior Vena Cava
Vasoconstriction
Constriction
Ventilation
Thorax
Gases
Pressure

All Science Journal Classification (ASJC) codes

  • Physiology

Cite this

@article{76e3085200954af19a08be72af497415,
title = "Pentobarbital augments pulmonary vasoconstrictor response to cyclooxygenase inhibition",
abstract = "We utilized multipoint pulmonary vascular pressure-flow (P/Q̇) plots to investigate the effects of pentobarbital sodium anesthesia on regulation of the pulmonary circulation by endogenous metabolites of the cyclooxygenase pathway. Our specific objective was to characterize the effects of two chemically dissimilar inhibitors of the cyclooxygenase pathway, indomethacin and sodium meclofenamate, on the pulmonary vascular P/Q̇ relationship measured in conscious and pentobarbital-anesthetized dogs. P/Q̇ plots were generated by graded constriction of the thoracic inferior vena cava, which produced stepwise decreases in Q̇. Controlled ventilation during pentobarbital anesthesia (30 mg/kg iv) allowed the matching of systemic arterial and mixed venous blood gases to conscious values. Pentobarbital had no net effect on the base-line P/Q̇ relationship compared with that measured in conscious dogs. Cyclooxygenase pathway inhibition with either indomethacin (5 mg/kg iv) or meclofenamate (2.5 mg/kg iv) resulted in active, flow-independent pulmonary vasoconstriction (P < 0.01) in both conscious and pentobarbital-anesthetized dogs. However, the magnitude of the pulmonary vasoconstrictor response to indomethacin was increased (P < 0.05) over a broad range of Q̇, and the pulmonary vasoconstrictor response to meclofenamate was increased (P < 0.05) over the entire range of Q̇ in pentobarbital-anesthetized compared with conscious dogs. Thus regulation of the base-line pulmonary vascular P/Q̇ relationship by endogenous metabolites of the cyclooxygenase pathway in conscious dogs is altered during pentobarbital anesthesia.",
author = "Nyhan, {D. P.} and Chen, {B. B.} and David Fehr and Goll, {H. M.} and Murray, {P. A.}",
year = "1989",
language = "English (US)",
volume = "257",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

Pentobarbital augments pulmonary vasoconstrictor response to cyclooxygenase inhibition. / Nyhan, D. P.; Chen, B. B.; Fehr, David; Goll, H. M.; Murray, P. A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 257, No. 4, 1989.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pentobarbital augments pulmonary vasoconstrictor response to cyclooxygenase inhibition

AU - Nyhan, D. P.

AU - Chen, B. B.

AU - Fehr, David

AU - Goll, H. M.

AU - Murray, P. A.

PY - 1989

Y1 - 1989

N2 - We utilized multipoint pulmonary vascular pressure-flow (P/Q̇) plots to investigate the effects of pentobarbital sodium anesthesia on regulation of the pulmonary circulation by endogenous metabolites of the cyclooxygenase pathway. Our specific objective was to characterize the effects of two chemically dissimilar inhibitors of the cyclooxygenase pathway, indomethacin and sodium meclofenamate, on the pulmonary vascular P/Q̇ relationship measured in conscious and pentobarbital-anesthetized dogs. P/Q̇ plots were generated by graded constriction of the thoracic inferior vena cava, which produced stepwise decreases in Q̇. Controlled ventilation during pentobarbital anesthesia (30 mg/kg iv) allowed the matching of systemic arterial and mixed venous blood gases to conscious values. Pentobarbital had no net effect on the base-line P/Q̇ relationship compared with that measured in conscious dogs. Cyclooxygenase pathway inhibition with either indomethacin (5 mg/kg iv) or meclofenamate (2.5 mg/kg iv) resulted in active, flow-independent pulmonary vasoconstriction (P < 0.01) in both conscious and pentobarbital-anesthetized dogs. However, the magnitude of the pulmonary vasoconstrictor response to indomethacin was increased (P < 0.05) over a broad range of Q̇, and the pulmonary vasoconstrictor response to meclofenamate was increased (P < 0.05) over the entire range of Q̇ in pentobarbital-anesthetized compared with conscious dogs. Thus regulation of the base-line pulmonary vascular P/Q̇ relationship by endogenous metabolites of the cyclooxygenase pathway in conscious dogs is altered during pentobarbital anesthesia.

AB - We utilized multipoint pulmonary vascular pressure-flow (P/Q̇) plots to investigate the effects of pentobarbital sodium anesthesia on regulation of the pulmonary circulation by endogenous metabolites of the cyclooxygenase pathway. Our specific objective was to characterize the effects of two chemically dissimilar inhibitors of the cyclooxygenase pathway, indomethacin and sodium meclofenamate, on the pulmonary vascular P/Q̇ relationship measured in conscious and pentobarbital-anesthetized dogs. P/Q̇ plots were generated by graded constriction of the thoracic inferior vena cava, which produced stepwise decreases in Q̇. Controlled ventilation during pentobarbital anesthesia (30 mg/kg iv) allowed the matching of systemic arterial and mixed venous blood gases to conscious values. Pentobarbital had no net effect on the base-line P/Q̇ relationship compared with that measured in conscious dogs. Cyclooxygenase pathway inhibition with either indomethacin (5 mg/kg iv) or meclofenamate (2.5 mg/kg iv) resulted in active, flow-independent pulmonary vasoconstriction (P < 0.01) in both conscious and pentobarbital-anesthetized dogs. However, the magnitude of the pulmonary vasoconstrictor response to indomethacin was increased (P < 0.05) over a broad range of Q̇, and the pulmonary vasoconstrictor response to meclofenamate was increased (P < 0.05) over the entire range of Q̇ in pentobarbital-anesthetized compared with conscious dogs. Thus regulation of the base-line pulmonary vascular P/Q̇ relationship by endogenous metabolites of the cyclooxygenase pathway in conscious dogs is altered during pentobarbital anesthesia.

UR - http://www.scopus.com/inward/record.url?scp=0024436322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024436322&partnerID=8YFLogxK

M3 - Article

C2 - 2508492

AN - SCOPUS:0024436322

VL - 257

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 4

ER -